Intuitive Surgical

ISRG Health Care Market cap $134B as of Sep 14, 2026 16:00 ET S&P 500

Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 21, 2026

Revenue$2.89B +19% year over year

Gross profit$1.96B 68% margin

Operating profit$0.97B 34% margin

Net profit$0.82B 28% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	2.89	100%	+19%
Instruments & accessories	1.74	60%	+18%
Systems	0.69	24%	+19%
Services	0.47	16%	+21%
Cost of revenue	−0.93	32%
Gross profit	1.96	68% margin	+1pp
R&D	−0.37	13%	+0pp
SG&A	−0.62	21%	−2pp
Operating profit	0.97	34% margin	+3pp
Other income, net	0.08
Tax	−0.23
Net profit	0.82	28% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	2.77	100%	+23%
Instruments & accessories	1.69	61%	+23%
Systems	0.65	23%	+24%
Services	0.43	16%	+19%
Cost of revenue	−0.94	34%
Gross profit	1.83	66% margin	+1pp
R&D	−0.36	13%	−1pp
SG&A	−0.61	22%	−3pp
Operating profit	0.86	31% margin	+5pp
Other income, net	0.08
Tax	−0.11
Net profit	0.82	30% margin	−1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.87	100%	+19%
Instruments & accessories	1.66	58%	+17%
Systems	0.79	27%	+20%
Services	0.42	15%	+21%
Cost of revenue	−0.96	34%
Gross profit	1.90	66% margin	−2pp
R&D	−0.35	12%	+0pp
SG&A	−0.69	24%	−1pp
Operating profit	0.86	30% margin	+0pp
Other income, net	0.09
Tax	−0.16
Net profit	0.80	28% margin	−1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.51	100%	+23%
Instruments & accessories	1.52	61%	+20%
Systems	0.59	23%	+33%
Services	0.40	16%	+20%
Cost of revenue	−0.84	34%
Gross profit	1.66	66% margin	−1pp
R&D	−0.33	13%	−1pp
SG&A	−0.57	23%	−2pp
Operating profit	0.76	30% margin	+2pp
Other income, net	0.09
Tax	−0.15
Net profit	0.70	28% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 21, 2026 Operating margin 34% Net profit $0.82B	Apr 1 – Jun 30, 2026	Jul 21, 2026	$2.89B	+19%	34%	$0.82B	28%
Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 22, 2026 Operating margin 31% Net profit $0.82B	Jan 1 – Mar 31, 2026	Apr 22, 2026	$2.77B	+23%	31%	$0.82B	30%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 3, 2026 Operating margin 30% Net profit $0.80B	Oct 1 – Dec 31, 2025	Feb 3, 2026	$2.87B	+19%	30%	$0.80B	28%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 22, 2025 Operating margin 30% Net profit $0.70B	Jul 1 – Sep 30, 2025	Oct 22, 2025	$2.51B	+23%	30%	$0.70B	28%